MOTIV BTK Randomized Controlled Trial
- Conditions
- Critical Limb Ischemia
- Interventions
- Device: MOTIV Sirolimus-Eluting Bioresorbable ScaffoldDevice: Percutaneous Transluminal Angioplasty (PTA) Device
- First Posted Date
- 2022-06-06
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 292
- Registration Number
- NCT05406622
- Locations
- πΊπΈ
Adventist Health, Saint Helena, California, United States
πΊπΈCardiovascular Medicine PC, Davenport, Iowa, United States
πΊπΈUnityPoint Health Trinity Bettendorf Hospital, Bettendorf, Iowa, United States
FANTOM Post Market Clinical Trial
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Fantom
- First Posted Date
- 2018-07-16
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 1500
- Registration Number
- NCT03587922
- Locations
- π¦πΉ
Wilhelminenhospital, Wien, Austria
π©πͺTechnische Universitat Dresden, Dresden, Germany
π©πͺJuedisches Krankenhaus Berlin, Berlin, Germany
Safety & Performance Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Fantom Sirolimus-Eluting Coronary Bioresorbable Scaffold
- First Posted Date
- 2015-09-03
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 272
- Registration Number
- NCT02539966
- Locations
- π¦πΊ
The Prince Charles Hospital, Chermside, Australia
π¦πΊSt Vincent's Hospital Sydney, Darlinghurst, Australia
π¦πΊPrince of Wales Hospital (Eastern Heart), Randwick, Australia
Pilot Study of the Fantom Bioresorbable Scaffold (FANTOM I)
- Conditions
- Coronary Artery Disease
- Interventions
- Device: Fantom Scaffold
- First Posted Date
- 2015-07-30
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT02512003
- Locations
- π§π·
Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
π΅π±Pracownia Kardiologii Inwazyjnej I Katedry i Kliniki Kardiologii WUM, Warszawa, Poland
ReZolve2 Clinical Investigation
- Conditions
- Coronary Artery DiseaseCoronary Artery Stenosis
- Interventions
- Device: ReZolve2 Scaffold
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 89
- Registration Number
- NCT01845311
- Locations
- π©πͺ
Cardioangiologisches Centrum Bethanien, Frankfurt, Germany
π¦πΊSt Vincent's Hospital, Sydney, Australia
π§π·Instituto Dante Pazzanese de Cariologia, Sao Paulo, Brazil
Safety Study of a Bioresorbable Coronary Stent
- Conditions
- Coronary Artery DiseaseMyocardial IschemiaCoronary Artery StenosisCardiovascular DiseaseCoronary DiseaseCoronary Restenosis
- Interventions
- Device: ReZolve Stent
- First Posted Date
- 2010-12-17
- Last Posted Date
- 2023-03-29
- Lead Sponsor
- REVA Medical, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT01262703
- Locations
- π§π·
Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil